These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37682871)

  • 1. Randomized Field Trial to Assess the Safety and Efficacy of Dihydroartemisinin-Piperaquine for Seasonal Malaria Chemoprevention in School-Aged Children in Bandiagara, Mali.
    Traore K; Coulibaly D; Kone AK; Guindo B; Traore S; Kouriba K; Djimde M; Thera MA
    J Infect Dis; 2024 Jan; 229(1):189-197. PubMed ID: 37682871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal Malaria Chemoprevention Therapy in Children Up To 9 Years of Age: Protocol for a Cluster-Randomized Trial Study.
    Toure M; Shaffer JG; Sanogo D; Keita S; Keita M; Kane F; Traore B; Dabitao D; Kone A; Doumbia CO; Keating J; Yukich J; Hansson HH; Barry AE; Diakité M; Alifrangis M; Doumbia S
    JMIR Res Protoc; 2024 Jan; 13():e51660. PubMed ID: 38252481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
    PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised trial to compare the safety, tolerability and efficacy of three drug combinations for intermittent preventive treatment in children.
    Bojang K; Akor F; Bittaye O; Conway D; Bottomley C; Milligan P; Greenwood B
    PLoS One; 2010 Jun; 5(6):e11225. PubMed ID: 20574538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Dama S; Niangaly H; Djimde M; Sagara I; Guindo CO; Zeguime A; Dara A; Djimde AA; Doumbo OK
    Malar J; 2018 Oct; 17(1):347. PubMed ID: 30290808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
    Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized Trial.
    NDiaye JL; Cissé B; Ba EH; Gomis JF; Ndour CT; Molez JF; Fall FB; Sokhna C; Faye B; Kouevijdin E; Niane FK; Cairns M; Trape JF; Rogier C; Gaye O; Greenwood BM; Milligan PJ
    PLoS One; 2016; 11(10):e0162563. PubMed ID: 27764102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
    Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
    Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
    Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
    Sundell K; Jagannathan P; Huang L; Bigira V; Kapisi J; Kakuru MM; Savic R; Kamya MR; Dorsey G; Aweeka F
    Malar J; 2015 Sep; 14():368. PubMed ID: 26403465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
    Zongo I; Milligan P; Compaore YD; Some AF; Greenwood B; Tarning J; Rosenthal PJ; Sutherland C; Nosten F; Ouedraogo JB
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4387-96. PubMed ID: 25918149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali.
    Cairns ME; Sagara I; Zongo I; Kuepfer I; Thera I; Nikiema F; Diarra M; Yerbanga SR; Barry A; Tapily A; Coumare S; Milligan P; Tinto H; Ouédraogo JB; Chandramohan D; Greenwood B; Djimde A; Dicko A
    PLoS Med; 2020 Aug; 17(8):e1003214. PubMed ID: 32822362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.
    Diawara F; Steinhardt LC; Mahamar A; Traore T; Kone DT; Diawara H; Kamate B; Kone D; Diallo M; Sadou A; Mihigo J; Sagara I; Djimde AA; Eckert E; Dicko A
    Malar J; 2017 Aug; 16(1):325. PubMed ID: 28797263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of intermittent preventive treatment in schoolchildren with sulfadoxine/pyrimethamine (SP) and SP plus piperaquine in Democratic Republic of the Congo: a randomised controlled trial.
    Matangila JR; Doua JY; Mitashi P; da Luz RI; Lutumba P; Van Geertruyden JP
    Int J Antimicrob Agents; 2017 Mar; 49(3):339-347. PubMed ID: 28108368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
    Kamya MR; Kapisi J; Bigira V; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Kakuru A; Aweeka FT; Huang L; Jagannathan P; Achan J; Havlir DV; Rosenthal PJ; Dorsey G
    AIDS; 2014 Nov; 28(18):2701-9. PubMed ID: 25493596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.